TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR

Brian D Lehmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.